1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents

Organic compounds -- part of the class 532-570 series – Organic compounds – Four or more ring nitrogens in the bicyclo ring system

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546201, 548336, 548468, 548486, C07D41304, C07D40104, C07D40304

Patent

active

048618802

ABSTRACT:
Certain substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones are highly potent gabaergic agents, valuable in the treatment of individuals suffering from schizophrenia or reversing the side effects of a previously or concurrently administered neuroleptic agent; or in the treatment of epilepsy. A wider class of substituted 1-phenyl-3-(aminoalkylidene)-2(1H,3H)-indolones, together with 1-phenyl-3-(2-pyrrolidinylidene)-2(1H,3H)-indolones, and homologs thereof, are valuable in the treatment of anxiety.

REFERENCES:
patent: 3043849 (1962-07-01), Szmuszkovicz
patent: 3215699 (1965-02-01), Shavel et al.
patent: 3506683 (1970-04-01), Anthony et al.
patent: 3642803 (1972-02-01), Welstead
patent: 4145422 (1979-03-01), Winn et al.
patent: 4332804 (1982-06-01), Clark
Lattrell et al., CA 89:179858y Indole-3-carbaldehyde oximes 1978, p. 594.
Meyers et al; Review of Medical Pharmacology, Lange Publicat. 4th 1974, p. 149.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-phenyl-2(1H,3H)-indolone psycho-therapeutic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2239426

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.